These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
501 related articles for article (PubMed ID: 19079157)
1. HIV infection and the gastrointestinal immune system. Brenchley JM; Douek DC Mucosal Immunol; 2008 Jan; 1(1):23-30. PubMed ID: 19079157 [TBL] [Abstract][Full Text] [Related]
2. Pathogenesis of HIV in the gastrointestinal tract. Dandekar S Curr HIV/AIDS Rep; 2007 Feb; 4(1):10-5. PubMed ID: 17338855 [TBL] [Abstract][Full Text] [Related]
3. Viral suppression and immune restoration in the gastrointestinal mucosa of human immunodeficiency virus type 1-infected patients initiating therapy during primary or chronic infection. Guadalupe M; Sankaran S; George MD; Reay E; Verhoeven D; Shacklett BL; Flamm J; Wegelin J; Prindiville T; Dandekar S J Virol; 2006 Aug; 80(16):8236-47. PubMed ID: 16873279 [TBL] [Abstract][Full Text] [Related]
4. Replication of M-tropic HIV-1 in activated human intestinal lamina propria lymphocytes is the main reason for increased virus load in the intestinal mucosa. Aziz S; Fackler OT; Meyerhans A; Müller-Lantzsch N; Zeitz M; Schneider T J Acquir Immune Defic Syndr; 2005 Jan; 38(1):23-30. PubMed ID: 15608520 [TBL] [Abstract][Full Text] [Related]
5. Mucosal immunity in HIV infection: what can be done to restore gastrointestinal-associated lymphoid tissue function? George MD; Asmuth DM Curr Opin Infect Dis; 2014 Jun; 27(3):275-81. PubMed ID: 24739345 [TBL] [Abstract][Full Text] [Related]
6. Altered CD4+ T cell homing to the gut impairs mucosal immune reconstitution in treated HIV-infected individuals. Mavigner M; Cazabat M; Dubois M; L'Faqihi FE; Requena M; Pasquier C; Klopp P; Amar J; Alric L; Barange K; Vinel JP; Marchou B; Massip P; Izopet J; Delobel P J Clin Invest; 2012 Jan; 122(1):62-9. PubMed ID: 22156200 [TBL] [Abstract][Full Text] [Related]
7. HIV infection and the gastrointestinal tract. Kotler DP AIDS; 2005 Jan; 19(2):107-17. PubMed ID: 15668535 [No Abstract] [Full Text] [Related]
8. HIV-1 infection of human intestinal lamina propria CD4+ T cells in vitro is enhanced by exposure to commensal Escherichia coli. Dillon SM; Manuzak JA; Leone AK; Lee EJ; Rogers LM; McCarter MD; Wilson CC J Immunol; 2012 Jul; 189(2):885-96. PubMed ID: 22689879 [TBL] [Abstract][Full Text] [Related]
9. HIV enteropathy and 'Slim disease': Historical and current perspectives. Kapembwa MS; Batman PA; Fleming SC; Griffin GE Int J Infect Dis; 2024 Feb; 139():86-91. PubMed ID: 38052315 [TBL] [Abstract][Full Text] [Related]
10. CD4+ T cells, including Th17 and cycling subsets, are intact in the gut mucosa of HIV-1-infected long-term nonprogressors. Ciccone EJ; Greenwald JH; Lee PI; Biancotto A; Read SW; Yao MA; Hodge JN; Thompson WL; Kovacs SB; Chairez CL; Migueles SA; Kovacs JA; Margolis LB; Sereti I J Virol; 2011 Jun; 85(12):5880-8. PubMed ID: 21471231 [TBL] [Abstract][Full Text] [Related]
11. Enhancement of HIV-1 infection and intestinal CD4+ T cell depletion ex vivo by gut microbes altered during chronic HIV-1 infection. Dillon SM; Lee EJ; Donovan AM; Guo K; Harper MS; Frank DN; McCarter MD; Santiago ML; Wilson CC Retrovirology; 2016 Jan; 13():5. PubMed ID: 26762145 [TBL] [Abstract][Full Text] [Related]
12. The effect of timing of antiretroviral therapy on CD4+ T-cell reconstitution in the intestine of HIV-infected patients. Allers K; Puyskens A; Epple HJ; Schürmann D; Hofmann J; Moos V; Schneider T Mucosal Immunol; 2016 Jan; 9(1):265-74. PubMed ID: 26129649 [TBL] [Abstract][Full Text] [Related]
13. The immunologic aspects of human immunodeficiency virus infection in the gastrointestinal tract. Schneider T; Ullrich R; Zeitz M Semin Gastrointest Dis; 1996 Jan; 7(1):19-29. PubMed ID: 8903576 [TBL] [Abstract][Full Text] [Related]
14. The mucosal immune system and HIV-1 infection. Veazey R; Lackner A AIDS Rev; 2003; 5(4):245-52. PubMed ID: 15012003 [TBL] [Abstract][Full Text] [Related]
15. Mucosal immunodeficiency in HIV/SIV infection. Zeitz M; Ullrich R; Schneider T; Kewenig S; Riecken E Pathobiology; 1998; 66(3-4):151-7. PubMed ID: 9693317 [TBL] [Abstract][Full Text] [Related]
16. Early antiretroviral therapy for simian immunodeficiency virus infection leads to mucosal CD4+ T-cell restoration and enhanced gene expression regulating mucosal repair and regeneration. George MD; Reay E; Sankaran S; Dandekar S J Virol; 2005 Mar; 79(5):2709-19. PubMed ID: 15708990 [TBL] [Abstract][Full Text] [Related]
17. On high alert. Marris E Nature; 2010 Jul; 466(7304):S2-3. PubMed ID: 20631700 [No Abstract] [Full Text] [Related]
18. Rapid onset of intestinal epithelial barrier dysfunction in primary human immunodeficiency virus infection is driven by an imbalance between immune response and mucosal repair and regeneration. Sankaran S; George MD; Reay E; Guadalupe M; Flamm J; Prindiville T; Dandekar S J Virol; 2008 Jan; 82(1):538-45. PubMed ID: 17959677 [TBL] [Abstract][Full Text] [Related]
19. Human immunodeficiency virus and the gastrointestinal immune system: does highly active antiretroviral therapy restore gut immunity? Costiniuk CT; Angel JB Mucosal Immunol; 2012 Nov; 5(6):596-604. PubMed ID: 22929559 [TBL] [Abstract][Full Text] [Related]
20. Th17 cells, HIV and the gut mucosal barrier. Dandekar S; George MD; Bäumler AJ Curr Opin HIV AIDS; 2010 Mar; 5(2):173-8. PubMed ID: 20543596 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]